Skip to content
drillr.ai
Sign up

4595.T

MIZUHO MEDY CO.,LTD.

スタンダード · 医薬品 · 医薬品 · JP

JPY 1,715.00
−0.46%
Ask drillr

  • Aug 12, 2026, 03:00 UTC

    Mizuho Medy announced its financial results for the first half of fiscal year ending December 2026, with recurring profit down 20.5% year-on-year to 1.11 billion yen, and second-quarter (April-June) recurring profit down 13.5% to 280 million yen.

    Source:

  • Jul 17, 2026, 04:35 UTC

    Mizuho Medy announced it will launch the Smart Gene Pertussis nucleic acid kit on August 3, 2026.

    Source: